Cita APA

Juengel, E., Nowaz, S., Makarevi, J., Natsheh, I., Werner, I., Nelson, K., . . . Blaheta, R. A. (2014). HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A. BioMed Central.

Chicago Style Citation

Juengel, Eva, et al. HDAC-inhibition Counteracts Everolimus Resistance in Renal Cell Carcinoma in Vitro By Diminishing Cdk2 and Cyclin A. BioMed Central, 2014.

Cita MLA

Juengel, Eva, et al. HDAC-inhibition Counteracts Everolimus Resistance in Renal Cell Carcinoma in Vitro By Diminishing Cdk2 and Cyclin A. BioMed Central, 2014.